Fear of new virus variant pushes U.S. toward more genomic sequencing – MarketWatch

The United Kingdoms use of genomic sequencing to identify a more infectious strain of SARS-CoV-2 has largely served as a wake-up call for inadequate use of the technology in the U.S. Up until mid-December, the U.S. had sequenced about 0.3% of its COVID-19 samples, a percentage that is significantly lower than other developed countries despite the fact that it has one-fourth of the worlds cases. In comparison, the U.K. is sequencing about 10% of its samples, and Australia aims to real-time sequence…

Click here to view the original article.